152 related articles for article (PubMed ID: 35583915)
1. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.
Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN
Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915
[TBL] [Abstract][Full Text] [Related]
2. PROPHYLACTIC n CMT-3 ATTENUATES SEPSIS-INDUCED ACUTE KIDNEY INJURY IN ASSOCIATION WITH NLRP3 INFLAMMASOME ACTIVATION AND APOPTOSIS.
Ma J; Wang X; Gu R; Guo D; Shi C; Kollisch-Singule M; Suo L; Luo J; Meng Q; Cooney RN
Shock; 2023 Jun; 59(6):922-929. PubMed ID: 36939682
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
4. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
5. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil elastase ameliorates matrix metalloproteinase-9 to promote lipopolysaccharide-induced acute lung injury in mice 1.
Guo Y; Ma L; Zhang F; Sun R; Li T
Acta Cir Bras; 2016 Jun; 31(6):382-8. PubMed ID: 27355745
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
9. Glyburide attenuates ozone-induced pulmonary inflammation and injury by blocking the NLRP3 inflammasome.
Shao H; Huang L; Duan S; Gao M; Zhu J; Chen X; Zhu Y; Wang W; Yang Z; Wang X; Wang Z; Wang Z; Ba Y; Zhang R; Li C; Zhang Q; Wang J; Liu H; Wu W; Feng F
Environ Toxicol; 2020 Aug; 35(8):831-839. PubMed ID: 32167222
[TBL] [Abstract][Full Text] [Related]
10. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
11. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
Shan M; Wan H; Ran L; Ye J; Xie W; Lu J; Hu X; Deng S; Zhang W; Chen M; Wang F; Guo Z
Drug Des Devel Ther; 2024; 18():1369-1384. PubMed ID: 38681210
[TBL] [Abstract][Full Text] [Related]
12. The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury.
Jones HD; Crother TR; Gonzalez-Villalobos RA; Jupelli M; Chen S; Dagvadorj J; Arditi M; Shimada K
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):270-80. PubMed ID: 24007300
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3.
Liao H; Zhang S; Qiao J
Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284
[TBL] [Abstract][Full Text] [Related]
14. Critical role for the NLRP3 inflammasome during acute lung injury.
Grailer JJ; Canning BA; Kalbitz M; Haggadone MD; Dhond RM; Andjelkovic AV; Zetoune FS; Ward PA
J Immunol; 2014 Jun; 192(12):5974-83. PubMed ID: 24795455
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of total glucosides of White Paeony Capsules in ameliorating acute lung injury based on NLRP3 inflammasome].
Xu YJ; Wang XL; Mu WQ; Wen JC; Wang Y; Xiu Y; Dong X; Li JJ; Zhan XY; Xiao XH; Bai ZF
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2754-2765. PubMed ID: 38812176
[TBL] [Abstract][Full Text] [Related]
16. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
Du ZA; Sun MN; Hu ZS
Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
[TBL] [Abstract][Full Text] [Related]
18. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
Zhang J; Wang C; Wang H; Li X; Xu J; Yu K
Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777
[TBL] [Abstract][Full Text] [Related]
19. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.
Lin Y; Yang Y
Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of GGPPS1 attenuated LPS-induced acute lung injury and was associated with NLRP3 inflammasome suppression.
Xu WJ; Wang XX; Jin JJ; Zou Q; Wu L; Lv TF; Wan B; Zhan P; Zhu SH; Liu HB; Zhao NW; Li CJ; Song Y
Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L567-L577. PubMed ID: 30652497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
